Medical Coatings Market

The medical coatings market is projected to grow from USD 10.92 billion in 2026 to USD 17.42 billion by 2031, at a CAGR of 9.8% during the forecast period.

Drivers for the growth of the medical coatings market are the growing demand for minimally invasive medical procedures, the increasing incidence of chronic diseases, and the growing importance of medical devices' improved efficiency and safety. Today's medical coatings must offer enhanced properties such as lubricity, biocompatibility, durability, anti-corrosion capability, and antimicrobial properties. Strict regulatory demands and the growing focus on patient safety are prompting medical device manufacturers to adopt high-quality coatings for their products. The increased usage of catheters, guidewires, stents, implants, and other complicated medical devices is an additional driver of the medical coatings market's growth. Key players in the market include Hydromer (US), DSM-Firmenich (Netherlands), Surmodics (US), Biocoat Incorporated (US), AST Products Inc (US), Covalon Technologies (Canada), Freudenberg Medical (US), Harland Medical Systems, Inc (US), Merit Medical Systems (US), Applied Medical Coatings (US), PPG Industries, Inc. (US), and The Sherwin-Williams Company (US), among others. These companies are strong in their home regions and are exploring geographic diversification options to grow their businesses. They focus on increasing their market shares through product launches and expansions.

To know about the assumptions considered for the study download the pdf brochure

Hydromer

Hydromer is a leading global provider of hydrophilic medical coatings and biopolymers, offering a comprehensive line of products for various medical applications. Hydromer's business operates through two divisions: polymer research and medical products. The polymer research division focuses on research and development services; this segment generates contract revenue and royalties from an extensive portfolio of medical coatings, including primers, thromboresistant coatings, coatings that keep devices hydrophilic after insertion, and coatings that promote cell growth. The company serves the medical coatings market across the urology, cardiology, and neurovascular sectors. Hydromer licenses its proprietary lubricious coating technologies, enabling customers to leverage innovative coating solutions. The company also provides standstill agreements that allow customers to evaluate product-process feasibility, test market products, and potentially enter long-term licensing, supply, or support agreements. Geographically, Hydromer operates in North America, Europe, and Asia Pacific, with most revenues coming from the US. The company is headquartered in Concord, North Carolina, and previously operated a manufacturing facility in Branchburg, New Jersey, which has now been relocated to Concord.

DSM-Firmenich

DSM-Firmenich, a science-based global company, operates through three segments: Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care, following its agreement in February 2026 to divest the Animal Nutrition & Health business to CVC Capital Partners. The company offers a wide range of solutions related to nutrition, health, and sustainable living. The Health, Nutrition & Care segment, through its Biomedical division, provides medical coatings, drug delivery platforms, and various biomedical materials, including bioceramics, biomedical polyethylenes, biomedical polyurethanes, collagen, and ophthalmic biomaterials. DSM-Firmenich operates globally, supporting customers in the medical coatings market through its extensive network of over 110 commercial production facilities in more than 40 countries. Major manufacturing sites for DSM Biomedical are located in the United States, Europe, and Asia, with significant facilities in countries such as the Netherlands, the US, and Japan. The company's innovation centers focus on promising growth areas, such as DSM Biomedical, developing disruptive material concepts for medical devices that address previously unmet clinical needs. One example is the production of low-cost, durable, and minimally invasive replacement heart valves. With a focus on innovation, customer satisfaction, and product development, DSM-Firmenich has numerous opportunities for growth and momentum in the medical coatings market.

Surmodics

Surmodics Inc. is a leading provider of surface modification coating technologies and in vitro diagnostic products for the medical device and in vitro diagnostics markets. Surmodics' medical coatings include lubricious hydrophilic coatings, hemocompatible hydrophilic coatings, and drug delivery coatings designed to enhance the performance and safety of medical devices. Moreover, Surmodics is committed to innovation and develops and commercializes its surface modification coating technologies through licensing agreements with third-party medical device manufacturers. The company protects its intellectual property with a strong patent portfolio. In November 2025, Surmodics was acquired by private equity firm GTCR, which also holds a majority stake in Biocoat, and is now privately held. Surmodics' operations are mainly based in the United States, where it has its headquarters and manufacturing facility in Eden Prairie, Minnesota, along with a limited presence in Europe, including a subsidiary in the United Kingdom. The company serves various customers in the medical device industry, and the organization continually develops medical coatings for a wide range of applications, such as cardiovascular, orthopedic, and neurovascular devices, among others. Surmodics' dedication to innovation and customer satisfaction ensures it remains a trusted partner for medical device manufacturers worldwide.

MEDICAL COATINGS MARKET: COMPANY EVALUATION MATRIX

Hydromer (Star) is a leading company in the medical coatings market due to the variety of hydrophilic, antimicrobial, lubricious, and specialized coatings available to cover medical devices, as well as coating development and application capabilities of the company. It provides coating services for catheters, guidewires, cardiovascular devices, urological devices, and other minimally invasive medical devices and assists manufacturers in improving lubricity, reducing friction, enhancing biocompatibility, and achieving better results with the use of medical devices. Applied Medical Coatings (Emerging) is an emerging company in the medical coatings market because of its advanced medical coating technologies, customized coating solutions, and surface treatment services for medical device manufacturers. This company is able to develop functional coatings that would improve the performance, longevity, lubricity, and biocompatibility of medical devices.

MEDICAL COATINGS MARKET: MARKET RANKING

The ranking of companies in the medical coatings market is based on several key factors that reflect their market position, capabilities, and overall contribution to the industry. The top 5 players in the market have been identified based on their revenue, market share, product offerings, production capacity, innovation, technological advancements, geographical presence, strategic partnerships, financial performance, and sustainability efforts. These key players continue to lead the medical coatings market by maintaining a competitive edge and delivering products to various end-use industries. Major players operating in the market are Hydromer (US), DSM-Firmenich (Netherlands), Surmodics (US), Biocoat Incorporated (US), AST Products Inc (US), Covalon Technologies (Canada), Freudenberg Medical (US), Harland Medical Systems, Inc (US), Merit Medical Systems (US), Applied Medical Coatings (US), PPG Industries, Inc. (US), and The Sherwin-Williams Company (US), among others.

Related Reports:

Medical Coatings Market by Coating Type (Active, Passive), By Material (Polymers, Metals), By Substrate (Metals, Polymers, Ceramics), By Application (Medical Devices, Medical Implants, Medical Equipment & Tools), By Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]